# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA918576 | F | Antiviral activity against camelpox virus by CPE assay | Camelpox virus | 6 | organism-based format | Scientific Literature | ||
2. | ALA1007603 | F | Antiviral activity against Camelpox virus in HFF cells assessed as inhibition of viral replication after 7 days | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
3. | ALA995354 | F | Antiviral activity against Camelpox virus CML1 infected in HEL299 cells assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | organism-based format | Scientific Literature | ||
4. | ALA995355 | F | Antiviral activity against Camelpox virus CML14 infected in HEL299 cells assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | organism-based format | Scientific Literature | ||
5. | ALA995359 | F | Antiviral activity against Camelpox virus CML1 infected in human PHK assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | organism-based format | Scientific Literature | ||
6. | ALA995360 | F | Antiviral activity against Camelpox virus CML14 infected in human PHK assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | organism-based format | Scientific Literature | ||
7. | ALA995366 | F | Antiviral activity against Camelpox virus CML1 infected in HEL299 cells assessed as reduction in viral titer after 6 days postinfection by virus yield reduction assay | Camelpox virus | 11 | organism-based format | Scientific Literature | ||
8. | ALA995367 | F | Antiviral activity against Camelpox virus CML14 infected in HEL299 cells assessed as reduction in viral titer after 6 days postinfection by virus yield reduction assay | Camelpox virus | 10 | organism-based format | Scientific Literature | ||
9. | ALA995368 | F | Antiviral activity against Camelpox virus CML1 infected in human PHK assessed as reduction in viral titer after 6 days postinfection by virus yield reduction assay | Camelpox virus | 10 | organism-based format | Scientific Literature | ||
10. | ALA995369 | F | Antiviral activity against Camelpox virus CML14 infected in human PHK assessed as reduction in viral titer after 6 days postinfection by virus yield reduction assay | Camelpox virus | 10 | organism-based format | Scientific Literature | ||
11. | ALA995370 | F | Antiviral activity against Camelpox virus CML1 infected in HEL299 cells assessed as inhibition of viral replication at 5 to 13 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
12. | ALA995371 | F | Antiviral activity against Camelpox virus CML14 infected in HEL299 cells assessed as inhibition of viral replication at 5 to 13 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
13. | ALA995372 | F | Antiviral activity against Camelpox virus CML1 infected in human PHK assessed as inhibition of viral replication at 5 to 13 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
14. | ALA995373 | F | Antiviral activity against Camelpox virus CML14 infected in human PHK assessed as inhibition of viral replication at 5 to 13 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
15. | ALA995374 | F | Antiviral activity against Camelpox virus CML1 infected in HEL299 cells assessed as complete inhibition of viral replication at 0.4 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
16. | ALA995375 | F | Antiviral activity against Camelpox virus CML14 infected in HEL299 cells assessed as complete inhibition of viral replication at 0.4 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
17. | ALA995376 | F | Antiviral activity against Camelpox virus CML1 infected in human PHK assessed as complete inhibition of viral replication at 4 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
18. | ALA995377 | F | Antiviral activity against Camelpox virus CML14 infected in human PHK assessed as complete inhibition of viral replication at 4 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 1 | organism-based format | Scientific Literature | ||
19. | ALA995378 | F | Antiviral activity against Camelpox virus CML1 infected in HEL299 cells assessed as suppression of viral replication at 73 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 2 | organism-based format | Scientific Literature | ||
20. | ALA995379 | F | Antiviral activity against Camelpox virus CML14 infected in HEL299 cells assessed as suppression of viral replication at 73 uM after 6 days postinfection by virus yield reduction assay | Camelpox virus | 2 | organism-based format | Scientific Literature |